From 99DOTS to 99DOTSLite in Gujarat: A Pragmatic Leap in TB Treatment Adherence
DOI:
https://doi.org/10.51957/Healthline_H761_2025Keywords:
99DOTS, 99DOTSLITE, DOTS, Treatment Adherence, TuberculosisAbstract
In 2013, Microsoft Research India launched a digital adherence technology (DAT) called 99DOTS which was created to overcome low treatment adherence in India's tuberculosis (TB) program. It employed the use of envelope-based medication delivery with concealed numbers which were unlocked and dialed by the patient to record compliance. Although successful in small-scale pilots, widespread adoption revealed several weaknesses such as dependence on packaging, complexity, and imprecision. To address these, the Central TB Division introduced a simplified version of its system, 99DOTSLite, in 2023, which relies on district-specific toll-free numbers (TFNs) printed on the medication packs or ID cards. Patients verify intake by making a missed call which gets automatically registered in Ni-kshay and thus followed up in real time in case of missed doses. In comparison to the previous systems, 99DOTSLite is affordable, compatible with any TB regimen, user-friendly, and easily integrated with the digital TB environment of India. Even though issues with phone access, connection, and possible false reporting are possible, 99DOTSLite is an open-ended, patient-centered innovation essential to India TB elimination activities.
References
1. World Health Organization. Global Tuberculosis Report 2023. Geneva: WHO; 2023.
2. Microsoft Research India. 99DOTS: a digital adherence technology for TB. 2018.
3. Oberoi S, Gupta VK, Chaudhary N, Singh A. 99 DOTS. Int J Contemp Med Res. 2016;3:2760–2.
4. Thomas BE, Kumar JV, Chiranjeevi M, Shah D, Khandewale A, Thiruvengadam K, et al. Evaluation of the Accuracy of 99DOTS, a Novel Cellphone-based Strategy for Monitoring Adherence to Tuberculosis Medications: Comparison of Digital Adherence Data With Urine Isoniazid Testing. Clin Infect Dis. 2020 Dec 3;71(9):e513-e516. doi: 10.1093/cid/ciaa333 DOI: https://doi.org/10.1093/cid/ciaa333
5. Hindustan Times Tech. World TB Day: Microsoft’s 99DOTS project enrolled over 93,000 patients in four years. 24 Mar 2017.
6. Central TB Division, MoHFW. Final Operational Guidance for Implementation of 99DOTSLite. New Delhi: Govt. of India; 2023. Accessed 9 Jul 2025.
7. Thomas BE, Kumar JV, Onongaya C, Bhatt SN, Galivanche A, Periyasamy M, et al. Explaining Differences in the Acceptability of 99DOTS, a Cell Phone-Based Strategy for Monitoring Adherence to Tuberculosis Medications: Qualitative Study of Patients and Health Care Providers. JMIR Mhealth Uhealth. 2020 Jul 31;8(7):e16634. doi: 10.2196/16634 DOI: https://doi.org/10.2196/16634
8. Rosu L, Madan J, Bronson G, Nidoi J, Tefera MG, Malaisamy M, et al. Cost of digital technologies and family-observed DOT for a shorter MDR-TB regimen: a modelling study in Ethiopia, India and Uganda. BMC Health Serv Res. 2023 Nov 18;23(1):1275. doi: 10.1186/s12913-023-10295-z DOI: https://doi.org/10.1186/s12913-023-10295-z
9. Kumar AA, De Costa A, Das A, Srinivasa GA, D'Souza G, Rodrigues R. Mobile Health for Tuberculosis Management in South India: Is Video-Based Directly Observed Treatment an Acceptable Alternative? JMIR Mhealth Uhealth. 2019 Apr 3;7(4):e11687. doi: 10.2196/11687 DOI: https://doi.org/10.2196/11687
10. Ray D. Digital programme to monitor TB patients launched in Ranchi. Times of India, 19 Apr 2023. [Accessed 9 Jul 2025]
11. Thakkar D, Piparva KG, Lakkad SG. A pilot project: 99DOTS information communication technology-based approach for tuberculosis treatment in Rajkot district. Lung India. 2019 Mar-Apr;36(2):108-111. doi: 10.4103/lungindia.lungindia_86_18 DOI: https://doi.org/10.4103/lungindia.lungindia_86_18
12. Ni-kshay Portal. Government of India digital TB dashboard. MoHFW. [Accessed 9 Jul 2025]
Downloads
Published
License
Copyright (c) 2025 Mittal Rathod, Harsha Solanki (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Articles in "Healthline Journal" are Open Access articles. The license permits use, distribution and reproduction in any medium for non-commercial purposes only, provided the original work and source is properly cited, and the new creations are licensed under the identical terms.
